Original article title
Pectolinarigenin suppresses colorectal cancer progression through metabolism-associated signaling.
Abstract conclusion
“PEC exhibits antitumor activity against CRC and is associated with coordinated changes in glycolysis-associated molecules and AMPK/FOXO3a-related signaling.”
Keep in mind
Research · assess methods and limitations.
pubmed.ncbi.nlm.nih.gov · Full-text access depends on the publisher.
The excerpt is quoted from source text. The original title is preserved above.
This is a reading aid. Follow the source for methods, limitations, corrections, and clinical context.